108 related articles for article (PubMed ID: 21206385)
21. Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer.
Liu L; Wu J; Zhong R; Wu C; Zou L; Yang B; Chen W; Zhu B; Duan S; Yu D; Tan W; Nie S; Lin D; Miao X
Mol Carcinog; 2013 Dec; 52(12):923-31. PubMed ID: 22821704
[TBL] [Abstract][Full Text] [Related]
22. The association between polymorphisms in glutathione S-transferase (GSTM1 and GSTT1) and lung cancer outcome.
Gonlugur U; Pinarbasi H; Gonlugur TE; Silig Y
Cancer Invest; 2006; 24(5):497-501. PubMed ID: 16939958
[TBL] [Abstract][Full Text] [Related]
23. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients.
Sweeney C; Nazar-Stewart V; Stapleton PL; Eaton DL; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):527-33. PubMed ID: 12814998
[TBL] [Abstract][Full Text] [Related]
24. Pharmacogenomics in lung cancer chemotherapy: a review of what the oncologist should know.
D'Antonio C; Milano A; Righini R; Onesti CE; Bassanelli M; Falcone R; Paris I; Lauro S; Marchetti P
Anticancer Res; 2014 Oct; 34(10):5241-50. PubMed ID: 25275016
[TBL] [Abstract][Full Text] [Related]
25. Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer.
Smit EF; Burgers SA; Biesma B; Smit HJ; Eppinga P; Dingemans AM; Joerger M; Schellens JH; Vincent A; van Zandwijk N; Groen HJ
J Clin Oncol; 2009 Apr; 27(12):2038-45. PubMed ID: 19307503
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.
Improta G; Sgambato A; Bianchino G; Zupa A; Grieco V; La Torre G; Traficante A; Cittadini A
Anticancer Res; 2008; 28(5B):2941-6. PubMed ID: 19031937
[TBL] [Abstract][Full Text] [Related]
27. CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphism.
Nie Q; Yang XN; An SJ; Zhang XC; Yang JJ; Zhong WZ; Liao RQ; Chen ZH; Su J; Xie Z; Wu YL
Eur J Cancer; 2011 Sep; 47(13):1962-70. PubMed ID: 21616658
[TBL] [Abstract][Full Text] [Related]
28. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study.
Hung RJ; Brennan P; Canzian F; Szeszenia-Dabrowska N; Zaridze D; Lissowska J; Rudnai P; Fabianova E; Mates D; Foretova L; Janout V; Bencko V; Chabrier A; Borel S; Hall J; Boffetta P
J Natl Cancer Inst; 2005 Apr; 97(8):567-76. PubMed ID: 15840879
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetics in chemotherapy of colorectal cancer.
Henriette Tanja L; Guchelaar HJ; Gelderblom H
Best Pract Res Clin Gastroenterol; 2009; 23(2):257-73. PubMed ID: 19414151
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy-induced neutropenia does not correlate with DNA repair gene polymorphisms and treatment efficacy in advanced non-small-cell lung cancer patients.
Iranzo V; Sirera R; Bremnes RM; Blasco A; Jantus-Lewintre E; Tarón M; Berrocal A; Blasco S; Caballero C; Del Pozo N; Rosell R; Camps C
Clin Lung Cancer; 2011 Jul; 12(4):224-30. PubMed ID: 21726821
[TBL] [Abstract][Full Text] [Related]
31. The polymorphism and haplotypes of XRCC1 and survival of non-small-cell lung cancer after radiotherapy.
Yoon SM; Hong YC; Park HJ; Lee JE; Kim SY; Kim JH; Lee SW; Park SY; Lee JS; Choi EK
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):885-91. PubMed ID: 16199318
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib.
Ma F; Sun T; Shi Y; Yu D; Tan W; Yang M; Wu C; Chu D; Sun Y; Xu B; Lin D
Lung Cancer; 2009 Oct; 66(1):114-9. PubMed ID: 19201048
[TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population.
Kiyohara C; Horiuchi T; Takayama K; Nakanishi Y
J Thorac Oncol; 2012 Jun; 7(6):954-62. PubMed ID: 22525558
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetics of cancer drugs.
Hertz DL; Rae J
Annu Rev Med; 2015; 66():65-81. PubMed ID: 25386932
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms in the apoptotic pathway gene BCL-2 and survival in small cell lung cancer.
Knoefel LF; Werle-Schneider G; Dally H; Müller PJ; Edler L; Bartsch H; Tuengerthal S; Heussel CP; Reinmuth N; Thomas M; Risch A
J Thorac Oncol; 2011 Jan; 6(1):183-9. PubMed ID: 21107291
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenetics of DNA repair gene polymorphisms in non-small-cell lung carcinoma patients on platinum-based chemotherapy.
Zhang L; Ma W; Li Y; Wu J; Shi GY
Genet Mol Res; 2014 Jan; 13(1):228-36. PubMed ID: 24446315
[TBL] [Abstract][Full Text] [Related]
37. A meta-analytic review of ERCC1/MDR1 polymorphism and chemosensitivity to platinum in patients with advanced non-small cell lung cancer.
Wei HB; Hu J; Shang LH; Zhang YY; Lu FF; Wei M; Yu Y
Chin Med J (Engl); 2012 Aug; 125(16):2902-7. PubMed ID: 22932088
[TBL] [Abstract][Full Text] [Related]
38. Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility.
To-Figueras J; Gene M; Gomez-Catalan J; Galan C; Firvida J; Fuentes M; Rodamilans M; Huguet E; Estape J; Corbella J
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):337-42. PubMed ID: 9162298
[TBL] [Abstract][Full Text] [Related]
39. DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.
Ott K; Rachakonda PS; Panzram B; Keller G; Lordick F; Becker K; Langer R; Buechler M; Hemminki K; Kumar R
Ann Surg Oncol; 2011 Sep; 18(9):2688-98. PubMed ID: 21347786
[TBL] [Abstract][Full Text] [Related]
40. A rapid outcomes ascertainment system improves the quality of prognostic and pharmacogenetic outcomes from observational studies.
Bradbury PA; Heist RS; Kulke MH; Zhou W; Marshall AL; Miller DP; Su L; Park S; Temel J; Fidias P; Sequist L; Lynch TJ; Wain JC; Shepherd FA; Christiani DC; Liu G
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):204-11. PubMed ID: 18199725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
